Sweroside
CAS: 14215-86-2
Ref. 3D-FS73846
| 10mg | 183.00 € | ||
| 25mg | 329.00 € | ||
| 50mg | 469.00 € | ||
| 100mg | 760.00 € | ||
| 250mg | 1,430.00 € |
Product Information
- (4aS,5R,6S)-5-Ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one
- (4aS,5R,6S)-5-Ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one
- (4aS,5R,6S)-5-ethenyl-1-oxo-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl beta-D-glucopyranoside
- 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, (4aS,5R,6S)-
- 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, [4aS-(4aα,5β,6α)]-
Sweroside is a natural compound that belongs to the family of bioactive phenolic compounds. It has been shown to have anti-inflammatory and genotoxic activities. Sweroside also inhibits the production of serotonin in the brain and thereby prevents the onset of ischemia-reperfusion injury. In addition, sweroside has been found to be effective in treating myocardial infarct in rats and inhibiting 5-HT2 receptors. Sweroside can be detected using an analytical method involving HPLC with preparative hplc, human serum, or human osteosarcoma cells as a receptor. The active form of sweroside is loganic acid, which can be isolated from the fructus of Swerria erythrocarpa var. pendula (L.) Seem.
Chemical properties
Technical inquiry about: 3D-FS73846 Sweroside
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
